fig1

Figure 1. Step-by-step acquisition of unhealthy patterns of gut dysbiosis with the severity of liver disease in patients with MAFLD. TMAO: Trimethylamine-N-oxide; MAFLD: metabolic-associated fatty liver disease; HCC: hepatocellular carcinoma; LPS: lipopolysaccharides; SCFA: short-chain fatty acids.